Difference between revisions of "Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[unchecked revision][checked revision]
 
(336 intermediate revisions by 13 users not shown)
Line 1: Line 1:
 +
Welcome!   
 +
 +
 +
We are creating content for all diseases with genetic findings in the current WHO Classification of Tumours books.  Please join the effort!   
 +
 +
 +
To volunteer: 
 +
 +
#Select a link in the table to your book(s) of interest to view specific authorship opportunities.  Additional books are in the process of being added.
 +
#'''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]''' with your disease page of interest.  You will be connected with an Associate Editor to help guide you through the process.
 +
#Complete the brief '''[https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>]''' to receive your log-in credentials.  Information on [[Description of CCGA Roles|<u>Authorship and Other Roles</u>]] with the CCGA is available.
 +
  
 
{| class="wikitable"
 
{| class="wikitable"
−
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
+
|+BOOKS WITH CONTENT IN PROGRESS
 +
!Book Name
 +
!Book Edition
 +
!Book Acronym
 
|-
 
|-
−
!'''Disease'''!!'''Page Type'''!!'''Author'''!!'''Associate Editor'''
+
|[[HAEM5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues]]
−
!Author Content (Pending or Complete)
+
|5th
−
!Editor Reviewed (Date)
+
|HAEM5
−
!Notes
 
 
|-
 
|-
−
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
+
|[[CNS5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of the Central Nervous System]]
−
|Fabiola Quintero-Rivera (FQR)
+
|5th
−
|PENDING
+
|CNS5
−
|
 
−
|
 
 
|-
 
|-
−
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
+
|[[GTS5:Volunteer Assignments and Opportunities|WHO Classification of Genetic Tumour Syndromes]]
−
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
+
|5th
−
|FQR
+
|GTS5
−
|Complete
 
−
|
 
−
|
 
 
|-
 
|-
−
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
+
|[[BRST5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of the Breast]]
−
| ||FQR
+
|5th
−
|
+
|BRST5
−
|
 
−
|
 
 
|-
 
|-
−
|    Polycythaemia Vera  (PV)||Disease
+
|[[STBT5:Volunteer Assignments and Opportunities|WHO Classification of Soft Tissue and Bone Tumours]]
−
|Gokce A. Toruner
+
|5th
−
|FQR
+
|STBT5
−
|PENDING
+
|}
−
|
 
−
|
 
−
|-
 
−
|    Primary Myelofibrosis  (PMF)||Disease
 
−
|T. Niroshi  Senaratne
 
−
|FQR
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Essential  Thrombocythaemia (ET)||Disease
 
−
|Rebecca Smith
 
−
|FQR
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
 
−
|Mark Evans (trainee), Fabiola Quintero-Rivera
 
−
|FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
 
−
|Mark Evans (trainee)+ Fabiola Quintero-Rivera
 
−
|FQR
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|'''''Mastocytosis'''''||'''''Overview'''''|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Cutaneous  Mastocytosis||Disease
 
−
|Thuy Phung
 
−
|FQR
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Systemic Mastocytosis||Disease
 
−
|Shashi Shetty
 
−
|FQR
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Mast Cell Sarcoma||Disease
 
−
|Thuy Phung
 
−
|FQR
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
 
−
|FQR
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden
 
−
|FQR
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Daynna J.Wolff
 
−
|FQR
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
 
−
|FQR
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Daynna J.Wolff
 
−
|FQR
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
 
−
|Disease
 
−
|Daynna J. Wolff
 
−
|FQR
 
−
|PENDING
 
−
|
 
−
|NON-WHO ENTITY
 
−
|-
 
−
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
 
−
|Disease
 
−
|Daynna J. Wolff
 
−
|FQR
 
−
|PENDING
 
−
|
 
−
|NON-WHO ENTITY
 
−
|-
 
−
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
 
−
|FQR
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
 
−
|FQR
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
 
−
|FQR
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
 
−
|FQR
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
 
−
|FQR
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
 
−
|FQR
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''|| ||FQR
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du+Teresa Smolarek
 
−
|FQR
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu+Teresa Smolarek
 
−
|FQR
 
−
|COMPLETE
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu+Teresa Smolarek
 
−
|FQR
 
−
|COMPLETE
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du+Teresa Smolarek
 
−
|FQR
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du+Teresa Smolarek
 
−
|FQR
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu+Teresa Smolarek
 
−
|FQR
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu+Teresa Smolarek
 
−
|FQR
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du+Teresa Smolarek
 
−
|FQR
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
 
−
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)||JH / MS
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang||JH / MS
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori||JH / MS
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang||JH / MS
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
 
−
|JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca||JH / MS
 
−
|Complete
 
−
|
 
−
|Need permission for figure?  Update WHO?
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)||JH / MS
 
−
|Complete
 
−
|
 
−
|Add WHO reference
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)||JH / MS
 
−
|Complete
 
−
|
 
−
|Check reference format
 
−
|-
 
−
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|   Acute Myeloid Leukemia (AML) without  Maturation||Disease||Jennelle Hodge||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myeloid Leukemia (AML) with  Maturation||Disease||Jennelle Hodge||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp||JH / MS
 
−
|Complete
 
−
|
 
−
|Need permission for figure?
 
−
|-
 
−
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)||JH / MS
 
−
|Complete
 
−
|
 
−
|Check reference format
 
−
|-
 
−
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)||JH / MS
 
−
|Complete
 
−
|
 
−
|Check reference format
 
−
|-
 
−
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera||JH / MS
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease|| ||JH / MS
 
−
|??
 
−
|
 
−
|
 
−
|-
 
−
|    ??Acute Leukaemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease|| ||JH / MS
 
−
|??
 
−
|
 
−
|
 
−
|-
 
−
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
 
−
|Disease
 
−
|Kay Weng Choy + Greg Conboy (Monash Health)
 
−
|JH / MS
 
−
|Complete
 
−
|
 
−
|NON-WHO ENTITY
 
−
|-
 
−
|Acute Myeloid Leukemia (AML)  with NUP214-ABL1
 
−
|Disease
 
−
|Daynna Wolff+Jessica Snider (Path Resident)
 
−
|JH / MS
 
−
|PENDING
 
−
|
 
−
|NON-WHO ENTITY
 
−
|-
 
−
|Acute Myeloid Leukemia (AML)  with t(4;12)(q12;p13); CHIC2-ETV6
 
−
|Disease
 
−
|Daynna Wolff+ Paige Woodham (Path Resident)
 
−
|JH / MS
 
−
|PENDING
 
−
|
 
−
|NON-WHO ENTITY
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''|| ||Yassmine Akkari (YA)
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
 
−
|YA
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease||Ashwini Yenamandra +
 
  
−
Lisa Smith + Yassmine Akkari
 
−
|YA
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
 
−
|YA
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|NK-Lymphoblastic Leukemia/Lymphoma||Disease|| ||YA
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
 
−
|Disease
 
−
|Helene Bruyere
 
−
|YA
 
−
|PENDING
 
−
|
 
−
|NON-WHO ENTITY
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|       Monoclonal B-cell  Lymphocytosis||Disease||Honey Reddi
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
 
−
|SP
 
−
|Complete
 
−
|
 
−
|Malini to review
 
−
|-
 
−
|Hairy Cell Leukemia||Disease||Snehal Patel
 
−
|SP
 
−
|Complete
 
−
|
 
−
|Malini to review
 
−
|-
 
−
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|Malini to review
 
−
|-
 
−
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|Malini to review
 
−
|-
 
−
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
 
−
|SP
 
−
|Complete
 
−
|
 
−
|Malini to review
 
−
|-
 
−
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|   Waldenstrom  Macroglobulinemia||Disease||Honey Reddi
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Heavy Chain Diseases'''''||'''''Overview'''''|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Mu Heavy Chain  Disease||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|   Gamma Heavy Chain  Disease||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Alpha Heavy Chain  Disease||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Plasma Cell Myeloma  Variants||Disease||Zhenya Tang
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Plasmacytoma||Disease||Zhenya Tang
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|           Primary  Amyloidosis||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|           Light Chain  and Heavy Chain Deposition Disease||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|         POEMS Syndrome||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|         TEMPI Syndrome||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|Nodal Marginal Zone Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|Follicular Lymphoma||Disease||Ruthann Pfau
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Primary Cutaneous Follicle Centre Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    In Situ Mantle Cell  Neoplasia||Disease||Mahsa Khanlari
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease|| ||Greg Corboy (GC)
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|EBV-Positive Mucocutaneous Ulcer||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Lymphomatoid Granulomatosis||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Intravascular Large B-cell Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|ALK-Positive Large B-cell Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera||GC
 
−
|Complete
 
−
|
 
−
|
 
−
|-
 
−
|Primary Effusion Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|   Multicentric Castleman  Disease||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Burkitt Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Burkitt-Like Lymphoma with 11q Aberration||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease|| ||GC
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don||SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don||SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don||SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|Aggressive NK-cell Leukemia||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Severe Mosquito Bite  Allergy||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Adult T-cell Leukemia/Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don||SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Mycosis Fungoides||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Sézary Syndrome||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Lymphomatoid  Papulosis||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
 
−
|SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
 
−
|SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease|| ||SP
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
 
−
|SP
 
−
|PENDING
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''|| ||Associate Editor??
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Lymphomas Associated with HIV Infection||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
 
  
−
Fabiola Quintero-Rivera
+
{| class="wikitable"
−
|
+
|+BOOKS COMING SOON
−
|PENDING
+
!Book Name
−
|
+
!Book Edition
−
|
+
!Book Acronym
−
|-
 
−
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|          Monomorphic  B-cell PTLD||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|          Monomorphic  T/NK-cell PTLD||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Histiocytic Sarcoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|   Langerhans Cell  Histiocytosis||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|   Langerhans Cell  Sarcoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Indeterminate Dendritic Cell Tumour||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Interdigitating Dendritic Cell Sarcoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Follicular Dendritic Cell Sarcoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Fibroblastic Reticular Cell Tumor||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Disseminated Juvenile Xanthogranuloma||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|Erdheim-Chester Disease||Disease|| ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
| || || ||
 
−
|
 
−
|
 
−
|
 
−
|}
 
−
{| class="wikitable sortable"
 
−
|+Gene-Specific Pages
 
−
!'''Gene'''
 
−
!'''Author'''
 
−
!'''Associate Editor'''
 
−
!Author Content
 
−
(Pending or Complete)
 
−
!Editor Reviewed (Date)
 
−
!Notes
 
−
|-
 
−
|BCR
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|ABL1
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|RUNX1
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|RUNX1T1
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|MYH11
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|FLT3
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|NPM1
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|TP53
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|DNMT3A
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|CEBPA
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|IDH1
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|IDH2
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|PML
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|RARA
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|ETV6
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|KIT
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|CBFB
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|GATA2
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|PTEN
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|MLTT3
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|MECOM
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|FGFR1(FLT2)
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|KMT2A
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|DEK
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|NUP214
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|RBM15
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|MKL1
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|DDX41
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|ANKRD26
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|CUX1
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|TET2
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|EZH2
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|FOXP1
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|MYC
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|JAK2
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|WT1
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|CBL
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|NF1
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|SUZ12
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|ERG
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|EST2
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|RPS14
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|RB1
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|MPL
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|CHGA
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|CDH1
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|SRSF2
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|DNMT1
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|PRDX2
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|-
 
|-
−
|ASXL1
+
|[[DIG5:Volunteer Assignments and Opportunities|WHO Classification of Digestive System Tumours]]
−
|
+
|5th
−
|
+
|DIG5
−
|
 
−
|
 
−
|
 
 
|-
 
|-
−
|MN1
+
|[[EYE5:Volunteer Assignments and Opportunities|WHO Classification of Eye and Orbit Tumours]]
−
|
+
|5th
−
|
+
|EYE5
−
|
 
−
|
 
−
|
 
 
|-
 
|-
−
|SF3A1
+
|[[SKIN5:Volunteer Assignments and Opportunities|WHO Classification of Skin Tumours]]
−
|
+
|5th
−
|
+
|SKIN5
−
|
 
−
|
 
−
|
 
 
|-
 
|-
−
|EP300
+
|[[HAN5:Volunteer Assignments and Opportunities|WHO Classification of Head and Neck Tumours]]
−
|
+
|5th
−
|
+
|HAN5
−
|
 
−
|
 
−
|
 
 
|-
 
|-
−
|JARID2
+
|[[ENDO5:Volunteer Assignments and Opportunities|WHO Classification of Endocrine and Neuroendocrine Tumours]]
−
|
+
|5th
−
|
+
|ENDO5
−
|
 
−
|
 
−
|
 
 
|-
 
|-
−
|
+
|[[MALE5:Volunteer Assignments and Opportunities|WHO Classification of Urinary and Male Genital Tumours]]
−
|
+
|5th
−
|
+
|MALE5
−
|
 
−
|
 
−
|
 
 
|-
 
|-
−
|
+
|[[PEDS5:Volunteer Assignments and Opportunities|WHO Classification of Paediatric Tumours]]
−
|
+
|5th
−
|
+
|PEDS5
−
|
 
−
|
 
−
|
 
 
|-
 
|-
−
|
+
|[[THOR5:Volunteer Assignments and Opportunities|WHO Classification of Thoracic Tumours]]
−
|
+
|5th
−
|
+
|THOR5
−
|
 
−
|
 
−
|
 
 
|-
 
|-
−
|
+
|[[FEMA5:Volunteer Assignments and Opportunities|WHO Classification of Female Genital Tumours]]
−
|
+
|5th
−
|
+
|FEMA5
−
|
 
−
|
 
−
|
 
 
|}
 
|}

Latest revision as of 12:29, 27 June 2024

Welcome!


We are creating content for all diseases with genetic findings in the current WHO Classification of Tumours books. Please join the effort!


To volunteer:

  1. Select a link in the table to your book(s) of interest to view specific authorship opportunities. Additional books are in the process of being added.
  2. Contact us with your disease page of interest. You will be connected with an Associate Editor to help guide you through the process.
  3. Complete the brief Volunteer Form to receive your log-in credentials. Information on Authorship and Other Roles with the CCGA is available.


BOOKS WITH CONTENT IN PROGRESS
Book Name Book Edition Book Acronym
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 5th HAEM5
WHO Classification of Tumours of the Central Nervous System 5th CNS5
WHO Classification of Genetic Tumour Syndromes 5th GTS5
WHO Classification of Tumours of the Breast 5th BRST5
WHO Classification of Soft Tissue and Bone Tumours 5th STBT5


BOOKS COMING SOON
Book Name Book Edition Book Acronym
WHO Classification of Digestive System Tumours 5th DIG5
WHO Classification of Eye and Orbit Tumours 5th EYE5
WHO Classification of Skin Tumours 5th SKIN5
WHO Classification of Head and Neck Tumours 5th HAN5
WHO Classification of Endocrine and Neuroendocrine Tumours 5th ENDO5
WHO Classification of Urinary and Male Genital Tumours 5th MALE5
WHO Classification of Paediatric Tumours 5th PEDS5
WHO Classification of Thoracic Tumours 5th THOR5
WHO Classification of Female Genital Tumours 5th FEMA5
Retrieved from "https://ccga.io/index.php?title=Volunteer_Assignments_and_Opportunities&oldid=14522"